769 related articles for article (PubMed ID: 27068635)
1. Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.
Salvador AM; Nevers T; Velázquez F; Aronovitz M; Wang B; Abadía Molina A; Jaffe IZ; Karas RH; Blanton RM; Alcaide P
J Am Heart Assoc; 2016 Mar; 5(3):e003126. PubMed ID: 27068635
[TBL] [Abstract][Full Text] [Related]
2. Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure.
Nevers T; Salvador AM; Grodecki-Pena A; Knapp A; Velázquez F; Aronovitz M; Kapur NK; Karas RH; Blanton RM; Alcaide P
Circ Heart Fail; 2015 Jul; 8(4):776-87. PubMed ID: 26022677
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.
Higashikuni Y; Tanaka K; Kato M; Nureki O; Hirata Y; Nagai R; Komuro I; Sata M
J Am Heart Assoc; 2013 Nov; 2(6):e000267. PubMed ID: 24249711
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.
Li J; Yousefi K; Ding W; Singh J; Shehadeh LA
Cardiovasc Res; 2017 May; 113(6):633-643. PubMed ID: 28453726
[TBL] [Abstract][Full Text] [Related]
5. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
[TBL] [Abstract][Full Text] [Related]
6. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice.
Gogiraju R; Schroeter MR; Bochenek ML; Hubert A; Münzel T; Hasenfuss G; Schäfer K
Cardiovasc Res; 2016 Aug; 111(3):204-16. PubMed ID: 27207947
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Human ADAMTS13 Treatment Improves Myocardial Remodeling and Functionality After Pressure Overload Injury in Mice.
Witsch T; Martinod K; Sorvillo N; Portier I; De Meyer SF; Wagner DD
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29367415
[TBL] [Abstract][Full Text] [Related]
8. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
[TBL] [Abstract][Full Text] [Related]
9. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642
[TBL] [Abstract][Full Text] [Related]
10. Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure Overload.
Mohammadzadeh N; Melleby AO; Palmero S; Sjaastad I; Chakravarti S; Engebretsen KVT; Christensen G; Lunde IG; Tønnessen T
Cardiology; 2020; 145(3):187-198. PubMed ID: 31968347
[TBL] [Abstract][Full Text] [Related]
11. Relaxin Family Member Insulin-Like Peptide 6 Ameliorates Cardiac Fibrosis and Prevents Cardiac Remodeling in Murine Heart Failure Models.
Maruyama S; Wu CL; Yoshida S; Zhang D; Li PH; Wu F; Parker Duffen J; Yao R; Jardin B; Adham IM; Law R; Berger J; Di Marchi R; Walsh K
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29887522
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in mice.
Besnier M; Coquerel D; Favre J; Dumesnil A; Guerrot D; Remy-Jouet I; Mulder P; Djerada Z; Tamion F; Richard V; Ouvrard-Pascaud A
Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1279-H1288. PubMed ID: 29569957
[TBL] [Abstract][Full Text] [Related]
13. The GABA
Bu J; Huang S; Wang J; Xia T; Liu H; You Y; Wang Z; Liu K
Front Immunol; 2021; 12():670153. PubMed ID: 34135897
[TBL] [Abstract][Full Text] [Related]
14. FABP5 Deficiency Impairs Mitochondrial Function and Aggravates Pathological Cardiac Remodeling and Dysfunction.
Gao S; Li G; Shao Y; Wei Z; Huang S; Qi F; Jiao Y; Li Y; Zhang C; Du J
Cardiovasc Toxicol; 2021 Aug; 21(8):619-629. PubMed ID: 33929718
[TBL] [Abstract][Full Text] [Related]
15. Intermedin alleviates pathological cardiac remodeling by upregulating klotho.
Zhang LS; Liu Y; Chen Y; Ren JL; Zhang YR; Yu YR; Jia MZ; Ning ZP; Du J; Tang CS; Qi YF
Pharmacol Res; 2020 Sep; 159():104926. PubMed ID: 32502636
[TBL] [Abstract][Full Text] [Related]
16. Endothelial mineralocorticoid receptor contributes to systolic dysfunction induced by pressure overload without modulating cardiac hypertrophy or inflammation.
Salvador AM; Moss ME; Aronovitz M; Mueller KB; Blanton RM; Jaffe IZ; Alcaide P
Physiol Rep; 2017 Jun; 5(12):. PubMed ID: 28637706
[TBL] [Abstract][Full Text] [Related]
17. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.
Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K
Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822
[TBL] [Abstract][Full Text] [Related]
18. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: heart failure causes severe lung disease.
Chen Y; Guo H; Xu D; Xu X; Wang H; Hu X; Lu Z; Kwak D; Xu Y; Gunther R; Huo Y; Weir EK
Hypertension; 2012 Jun; 59(6):1170-8. PubMed ID: 22508832
[TBL] [Abstract][Full Text] [Related]
20. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
